These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16931511)

  • 21. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
    Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome.
    Ohno K; Engel AG; Shen XM; Selcen D; Brengman J; Harper CM; Tsujino A; Milone M
    Am J Hum Genet; 2002 Apr; 70(4):875-85. PubMed ID: 11791205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUSK, a new target for mutations causing congenital myasthenic syndrome.
    Chevessier F; Faraut B; Ravel-Chapuis A; Richard P; Gaudon K; Bauché S; Prioleau C; Herbst R; Goillot E; Ioos C; Azulay JP; Attarian S; Leroy JP; Fournier E; Legay C; Schaeffer L; Koenig J; Fardeau M; Eymard B; Pouget J; Hantaï D
    Hum Mol Genet; 2004 Dec; 13(24):3229-40. PubMed ID: 15496425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.
    Aharoni S; Sadeh M; Shapira Y; Edvardson S; Daana M; Dor-Wollman T; Mimouni-Bloch A; Halevy A; Cohen R; Sagie L; Argov Z; Rabie M; Spiegel R; Chervinsky I; Orenstein N; Engel AG; Nevo Y
    Neuromuscul Disord; 2017 Feb; 27(2):136-140. PubMed ID: 28024842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenic syndromes in Turkish kinships due to mutations in the acetylcholine receptor.
    Ohno K; Anlar B; Ozdirim E; Brengman JM; DeBleecker JL; Engel AG
    Ann Neurol; 1998 Aug; 44(2):234-41. PubMed ID: 9708546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.
    Milone M; Shen XM; Selcen D; Ohno K; Brengman J; Iannaccone ST; Harper CM; Engel AG
    Neurology; 2009 Jul; 73(3):228-35. PubMed ID: 19620612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common founder effect of rapsyn N88K studied using intragenic markers.
    Dunne V; Maselli RA
    J Hum Genet; 2004; 49(7):366-369. PubMed ID: 15252722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene.
    Müller JS; Petrova S; Kiefer R; Stucka R; König C; Baumeister SK; Huebner A; Lochmüller H; Abicht A
    Neuropediatrics; 2004 Jun; 35(3):183-9. PubMed ID: 15248101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Congenital myasthenic syndromes due to mutations in the rapsyn gene].
    Eymard B; Ioos C; Barois A; Estournet B; Mayer M; Fournier E; Yasaki E; Prioleau C; Bauché S; Gaudon K; Leroy JP; Koenig J; Richard P; Hantaï D
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S78-84. PubMed ID: 15269664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible founder effect of rapsyn N88K mutation and identification of novel rapsyn mutations in congenital myasthenic syndromes.
    Richard P; Gaudon K; Andreux F; Yasaki E; Prioleau C; Bauché S; Barois A; Ioos C; Mayer M; Routon MC; Mokhtari M; Leroy JP; Fournier E; Hainque B; Koenig J; Fardeau M; Eymard B; Hantaï D
    J Med Genet; 2003 Jun; 40(6):e81. PubMed ID: 12807980
    [No Abstract]   [Full Text] [Related]  

  • 33. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
    Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital myasthenic syndrome with episodic apnea in patients homozygous for a CHAT missense mutation.
    Kraner S; Laufenberg I; Strassburg HM; Sieb JP; Steinlein OK
    Arch Neurol; 2003 May; 60(5):761-3. PubMed ID: 12756141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital myasthenic syndromes: clinical and genetic analysis of 18 patients.
    Abicht A; Müller-Felber W; Fischer P; Jakob I; Kürz L; Rudel R; Mortier W; Pongratz D; Lochmüller H
    Eur J Med Res; 1997 Dec; 2(12):515-22. PubMed ID: 9498929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital Myasthenic Syndrome: Spectrum of Mutations in an Indian Cohort.
    Selvam P; Arunachal G; Danda S; Chapla A; Sivadasan A; Alexander M; Thomas MM; Thomas NJ
    J Clin Neuromuscul Dis; 2018 Sep; 20(1):14-27. PubMed ID: 30124556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis of congenital myasthenic syndrome with mutation of the RAPSN gene after general anaesthesia.
    Gentili A; Ansaloni S; Morello W; Cecini MT; Cordelli DM; Baroncini S
    Eur J Anaesthesiol; 2011 Oct; 28(10):748-9. PubMed ID: 21372719
    [No Abstract]   [Full Text] [Related]  

  • 39. The congenital myasthenic syndrome mutation RAPSN N88K derives from an ancient Indo-European founder.
    Müller JS; Abicht A; Burke G; Cossins J; Richard P; Baumeister SK; Stucka R; Eymard B; Hantaï D; Beeson D; Lochmüller H
    J Med Genet; 2004 Aug; 41(8):e104. PubMed ID: 15286164
    [No Abstract]   [Full Text] [Related]  

  • 40. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
    Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
    Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.